180 research outputs found

    Liquid Methane/Liquid Oxygen Propellant Conditioning Feed System (PCFS) Test Rigs

    Get PDF
    As part of their Propulsion and Cryogenic Advanced Development (PCAD) program, NASA has embarked upon an effort to develop chemical rocket engines which utilize non-toxic, cryogenic propellants such as liquid oxygen (LO2) and liquid methane (LCH4). This effort includes the development and testing of a 100 lbf Reaction Control Engine (RCE) that will be used to evaluate the performance of a LO2/LCH4 rocket engine over a broad range of propellant temperatures and pressures. This testing will take place at NASA-Glenn Research Center's (GRC) Research Combustion Laboratory (RCL) test facility in Cleveland, OH, and is currently scheduled to begin in late 2008. While the initial tests will be performed at sea level, follow-on testing will be performed at NASA-GRC's Altitude Combustion Stand (ACS) for altitude testing. In support of these tests, Sierra Lobo, Inc. (SLI) has designed, developed, and fabricated two separate portable propellant feed systems under the Propellant Conditioning and Feed System (PCFS) task: one system for LCH4, and one for LO2. These systems will be capable of supplying propellants over a large range of conditions from highly densified to several hundred pounds per square inch (psi) saturated. This paper presents the details of the PCFS design and explores the full capability of these propellant feed systems

    Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats

    Get PDF
    Painful stimuli during neonatal stage may affect brain development and contribute to abnormal behaviors in adulthood. Very few specific therapies are available for this developmental disorder. A better understanding of the mechanisms and consequences of painful stimuli during the neonatal period is essential for the development of effective therapies. In this study, we examined brain reactions in a neonatal rat model of peripheral inflammatory pain. We focused on the inflammatory insult-induced brain responses and delayed changes in behavior and pain sensation. Postnatal day 3 pups received formalin injections into the paws once a day for 3 days. The insult induced dysregulation of several inflammatory factors in the brain and caused selective neuronal cell death in the cortex, hippocampus and hypothalamus. On postnatal day 21, rats that received the inflammatory nociceptive insult exhibited increased local cerebral blood flow in the somatosensory cortex, hyperalgesia, and decreased exploratory behaviors. Based on these observations, we tested recombinant human erythropoietin (rhEPO) as a potential treatment to prevent the inflammatory pain-induced changes. rhEPO treatment (5,000 U/kg/day, i.p.), coupled to formalin injections, ameliorated neuronal cell death and normalized the inflammatory response. Rats that received formalin plus rhEPO exhibited normal levels of cerebral blood flow, pain sensitivity and exploratory behavior. Treatment with rhEPO also restored normal brain and body weights that were reduced in the formalin group. These data suggest that severe inflammatory pain has adverse effects on brain development and rhEPO may be a possible therapy for the prevention and treatment of this developmental disorder

    Comprehensive Gene and microRNA Expression Profiling Reveals a Role for microRNAs in Human Liver Development

    Get PDF
    BACKGROUND AND AIMS: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs post-transcriptionally. miRNAs have been implicated in regulating gene expression in embryonic developmental processes, including proliferation and differentiation. The liver is a multifunctional organ, which undergoes rapid changes during the developmental period and relies on tightly-regulated gene expression. Little is known regarding the complex expression patterns of both mRNAs and miRNAs during the early stages of human liver development, and the role of miRNAs in the regulation of this process has not been studied. The aim of this work was to study the impact of miRNAs on gene expression during early human liver development. METHODS: Global gene and miRNA expression were profiled in adult and in 9-12w human embryonic livers, using high-density microarrays and quantitative RT-PCR. RESULTS: Embryonic liver samples exhibited a gene expression profile that differentiated upon progression in the developmental process, and revealed multiple regulated genes. miRNA expression profiling revealed four major expression patterns that correlated with the known function of regulated miRNAs. Comparison of the expression of the most regulated miRNAs to that of their putative targets using a novel algorithm revealed a significant anti-correlation for several miRNAs, and identified the most active miRNAs in embryonic and in adult liver. Furthermore, our algorithm facilitated the identification of TGFbeta-R1 as a novel target gene of let-7. CONCLUSIONS: Our results uncover multiple regulated miRNAs and genes throughout human liver development, and our algorithm assists in identification of novel miRNA targets with potential roles in liver development
    corecore